Skip to main content
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ATOS ISIN · US04962H5063 US Manufacturing
Open in API
Filings indexed 622 across all filing types
Latest filing 2012-11-07 Director's Dealing
Country US United States of America
Listing US ATOS

About ATOSSA THERAPEUTICS, INC.

https://atossatherapeutics.com/

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines for areas of significant unmet medical need, with a primary focus on oncology. The company is dedicated to addressing the full continuum of breast cancer care. Its lead program is centered on (Z)-endoxifen, a proprietary and potent selective estrogen receptor modulator (SERM). Atossa is advancing (Z)-endoxifen through clinical development for multiple breast cancer indications, including metastatic disease, aiming to provide a therapeutic with a potentially improved efficacy and tolerability profile.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2012-11-07 English
PRIMARY DOCUMENT
Director's Dealing
2012-11-07 English
PRIMARY DOCUMENT
Director's Dealing
2012-11-07 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 12 to Form S-1 Registration Statement filed with the SEC, dated November 5, 2012, for Atossa Genetics Inc. It is a registration statement under the Securities Act of 1933, related to an initial public offering (IPO) of common stock. The text includes detailed information about the company, its business, risk factors, management discussion and analysis, financial condition, and other disclosures typical of an S-1 filing. This is a regulatory filing related to securities registration and offering, not a financial report, earnings release, or other types of filings. The S-1 registration statement and its amendments are considered Regulatory Filings (RNS) in the classification scheme, as they are general regulatory announcements and compliance documents that do not fit into other specific categories like Annual Report or Earnings Release. The document length is substantial (15,000 characters), and it is not merely an announcement of a report but the report itself (the registration statement). Therefore, the appropriate classification is Regulatory Filings (RNS).
2012-11-05 English
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the U.S. Securities and Exchange Commission requesting the effectiveness of a Registration Statement on Form S-1. It is a formal correspondence related to the regulatory process of a securities offering, specifically the activation of a registration statement. The document does not contain financial statements, management discussion, or detailed report content. It is a regulatory communication about the status of a filing, not the filing itself or a financial report. The length is short (2034 characters), and it is clearly a regulatory filing or correspondence with the SEC. Therefore, it fits best under Regulatory Filings (RNS).
2012-11-05 English
Capital/Financing Update 2012
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the SEC regarding a Registration Statement on Form S-1, specifically requesting acceleration of the effective date of the Registration Statement. It mentions distribution of the Preliminary Prospectus and compliance with SEC rules related to securities offerings. The content is related to capital raising and securities registration, not a financial report or earnings release. It is an update on financing activity and regulatory compliance for a capital raise. Therefore, the document fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Confidence is high due to clear references to Form S-1 and underwriting activities.
2012-11-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.